New Drug Treatment for Metastatic Pancreatic Cancer
Dr. Golan’s research offers new hope for patients worldwide with pancreatic cancer, particularly pancreatic adenocarcinoma harboring BRCA mutations. The results showed that patients who received the POLO treatment did significantly better overall than those who did not receive the drug.
Read More